Effects of Paraquat, Dextran Sulfate Sodium, and Irradiation on Behavioral and Cognitive Performance and the Gut Microbiome in A53T and A53T-L444P Mice
Authors:
- Ariel ChaklaiACAriel Chaklai
- Abigail O’neilAOAbigail O’neil
- Shrey GoelSGShrey Goel
- Nick MargoliesNMNick Margolies
- Destine KrenikDKDestine Krenik
- Ruby PerezRPRuby Perez
- Kat KesslerKKKat Kessler
- Elizabeth StaltontallESElizabeth Staltontall
- Hong Ki (Eric) YoonHYHong Ki (Eric) Yoon
- Montzerrat PantojaMPMontzerrat Pantoja
- Keaton StagamanKSKeaton Stagaman
- Kristin KasschauKKKristin Kasschau
Open Access
Abstract
Heterozygous carriers of the glucocerebrosidase 1 (GBA) L444P Gaucher mutation have an increased risk of developing Parkinson’s disease (PD). The GBA mutations result in elevated alpha synuclein (aSyn) levels. Heterozygous mice carrying one allele with the L444P mutation knocked-into the mouse gene show increased aSyn levels and are more sensitive to motor deficits following exposure to the neurotoxin (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) MPTP than wild-type mice. Paraquat (PQ), a herbicide, increases PD risk in most studies. Its effects on the brain involve alterations in the gut microbiome. Exposure to dextran sulfate sodium (DSS), a mouse model of colitis, can be used to determine whether gut microbiome alterations are sufficient to induce PD-relevant phenotypes. We rederived the A53T-L444P and A53T mouse lines to assess whether PQ, PQ in combination with radiation exposure (IR), and DSS have differential effects in A53T and A53T-L444P mice and whether these effects are associated with alterations in the gut microbiome. PQ and PQ + IR have differential effects in A53T and A53T-L444P mice. In contrast, effects of DSS are only seen in A53T-L444P mice. Exposure and genotype modulate the relationship between the gut microbiome and behavioral performance. The gut microbiome may be an important mediator of how environmental exposures or genetic mutations yield behavioral and cognitive impacts.Keywords
Funding Information
- OHSU Parkinson Center (NIH R21 AG079158, W81XWH2110703, NIH R01 ES030226-01)
This publication has 48 references indexed in Scilit:
- Chronic Mild Gut Inflammation Accelerates Brain Neuropathology and Motor Dysfunction in α-Synuclein Mutant MiceNeuroMolecular Medicine, 2019
- Developmental effects of neonatal fractionated co‐exposure to low‐dose gamma radiation and paraquat on behaviour in adult miceJournal of Applied Toxicology, 2018
- Brain–gut–microbiota axis — mood, metabolism and behaviourNature Reviews Gastroenterology & Hepatology, 2017
- Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s DiseaseCell, 2016
- Gut–brain axis: how the microbiome influences anxiety and depressionTrends in Neurosciences, 2013
- Diagnosis and Treatment of Depression Comorbid with Neurologic DisordersThe American Journal of Medicine, 2008
- Quality of life in Parkinson's disease: The relative importance of the symptomsMovement Disorders, 2008
- Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson diseaseNeurobiology of Aging, 2007
- Non-motor symptoms of Parkinson's disease: diagnosis and managementThe Lancet Neurology, 2006
- Environmental Risk Factors and Parkinson's Disease: Selective Degeneration of Nigral Dopaminergic Neurons Caused by the Herbicide ParaquatNeurobiology of Disease, 2002